Dimensional Fund Advisors
STSA

Dimensional Fund Advisors’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Dimensional Fund Advisors’s Portfolio STSA Stock Details STSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.66M Buy
276,266
+39,731
+17% +$225K ﹤0.01% 2765
2022
Q2 		$979K Buy
236,535
+16,671
+8% +$58.8K ﹤0.01% 2917
2022
Q1 		$835K Buy
219,864
+17,180
+8% +$77.4K ﹤0.01% 3032
2021
Q4 		$912K Sell
202,684
-30,079
-13% -$153K ﹤0.01% 3048
2021
Q3 		$1.08M Buy
232,763
+54,765
+31% +$290K ﹤0.01% 3034
2021
Q2 		$1.25M Buy
177,998
+125,745
+241% +$678K ﹤0.01% 2984
2021
Q1 		$309K Buy
+52,253
New +$317K ﹤0.01% 3220

Other funds holding STSA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors's STSA Position: Q3 2022 in Review

Dimensional Fund Advisors increased its Satsuma Pharmaceuticals, Inc. Common Stock (STSA) stake by 17% in Q3 2022, buying an estimated $225K and bringing the position to 276,266 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

Dimensional Fund Advisors first reported a position in STSA in Q1 2021 and has held it in 7 quarters since. 41 funds tracked by Wall St. Rank hold STSA as of Q3 2022.

  • Dimensional Fund Advisors held 276,266 shares of Satsuma Pharmaceuticals, Inc. Common Stock worth $1.66M as of Q3 2022.
  • Dimensional Fund Advisors bought 39,731 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $225K.
  • Satsuma Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2765 holding.
  • Dimensional Fund Advisors first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q1 2021 and has held it in 7 quarters since.
  • 41 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.